| Primary |
| Drug Use For Unknown Indication |
40.2% |
| Product Used For Unknown Indication |
22.1% |
| Sinusitis |
11.4% |
| Bronchitis |
6.3% |
| Pneumonia |
3.3% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Lobar Pneumonia |
1.8% |
| Menopausal Symptoms |
1.6% |
| Infection |
1.1% |
| Respiratory Tract Infection |
1.1% |
| Acute Sinusitis |
0.9% |
| Ear Infection |
0.9% |
| Helicobacter Infection |
0.9% |
| Hypertension |
0.9% |
| Lyme Disease |
0.9% |
| Nasopharyngitis |
0.9% |
| Pain |
0.9% |
| Abdominal Pain |
0.7% |
| Asthma |
0.7% |
|
| Medication Residue |
10.5% |
| Dysgeusia |
8.4% |
| Small Intestinal Obstruction |
7.4% |
| Tinnitus |
7.4% |
| Weight Bearing Difficulty |
7.4% |
| Nausea |
6.3% |
| Psychotic Disorder |
6.3% |
| Unevaluable Event |
6.3% |
| Vomiting |
6.3% |
| Rash |
5.3% |
| Urticaria |
4.2% |
| Clostridial Infection |
3.2% |
| Heart Rate Increased |
3.2% |
| Suicidal Ideation |
3.2% |
| Thinking Abnormal |
3.2% |
| Wheezing |
3.2% |
| Drug Interaction |
2.1% |
| Dyspnoea |
2.1% |
| Gastric Ulcer |
2.1% |
| Hepatitis |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
48.4% |
| Drug Use For Unknown Indication |
13.1% |
| Sinusitis |
6.5% |
| Chronic Obstructive Pulmonary Disease |
5.2% |
| Ear Infection |
3.3% |
| Tinea Pedis |
3.3% |
| Bronchitis |
2.6% |
| Nasopharyngitis |
2.6% |
| Cough |
2.0% |
| Pyrexia |
2.0% |
| Upper Respiratory Tract Infection |
2.0% |
| Erectile Dysfunction |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Renal Transplant |
1.3% |
| Seborrhoea |
1.3% |
| Atrial Fibrillation |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Cardiac Disorder |
0.7% |
| Hyperventilation |
0.7% |
|
| Wheezing |
14.3% |
| Drug Hypersensitivity |
11.4% |
| Rhabdomyolysis |
11.4% |
| Pyrexia |
8.6% |
| Gastric Ulcer |
5.7% |
| Nausea |
5.7% |
| Rash Pruritic |
5.7% |
| Decreased Appetite |
2.9% |
| Drug Ineffective |
2.9% |
| Hospitalisation |
2.9% |
| Hyperpyrexia |
2.9% |
| Medication Error |
2.9% |
| Pain |
2.9% |
| Pruritus |
2.9% |
| Renal Failure |
2.9% |
| Stomatitis |
2.9% |
| Thirst |
2.9% |
| Ulcer |
2.9% |
| Upper Respiratory Tract Infection |
2.9% |
| Urticaria |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
23.4% |
| Gastrooesophageal Reflux Disease |
7.1% |
| Depression |
5.1% |
| Pain |
4.7% |
| Headache |
3.8% |
| Restless Legs Syndrome |
3.5% |
| Asthma |
2.8% |
| Anxiety |
2.6% |
| Arthritis |
2.6% |
| Bipolar Disorder |
2.0% |
| Constipation |
2.0% |
| Multiple Myeloma |
2.0% |
| Contraception |
1.5% |
| Sinusitis |
1.5% |
| Tension Headache |
1.5% |
| Dyspepsia |
1.3% |
| Hepatic Cirrhosis |
1.3% |
| Myocardial Infarction |
1.3% |
| Hypersensitivity |
1.2% |
|
| Weight Decreased |
21.5% |
| Pulmonary Embolism |
9.3% |
| Vomiting |
8.4% |
| Weight Increased |
8.4% |
| Tremor |
6.5% |
| Deep Vein Thrombosis |
3.7% |
| Pain |
3.7% |
| Pyrexia |
3.7% |
| Suicidal Ideation |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Ventricular Hypoplasia |
3.7% |
| Convulsion Neonatal |
2.8% |
| Dyspnoea |
2.8% |
| Gallbladder Cholesterolosis |
2.8% |
| Myocardial Infarction |
2.8% |
| Pain In Extremity |
2.8% |
| Therapeutic Response Unexpected |
2.8% |
| Urinary Tract Infection |
2.8% |
| Biliary Dyskinesia |
1.9% |
| Dizziness |
1.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
24.0% |
| Dyslipidaemia |
8.0% |
| Fibromyalgia |
8.0% |
| Pain |
8.0% |
| Upper Respiratory Tract Infection |
8.0% |
| Bipolar Disorder |
4.0% |
| Bronchitis |
4.0% |
| Menopausal Symptoms |
4.0% |
| Sinusitis |
4.0% |
|
| Rhabdomyolysis |
28.6% |
| Upper Respiratory Tract Infection |
28.6% |
| Myalgia |
14.3% |
| Toxicity To Various Agents |
14.3% |
| Withdrawal Bleed |
14.3% |
|
